Skip to main content
. Author manuscript; available in PMC: 2015 Jun 19.
Published in final edited form as: J Pharm Sci. 2012 Apr 26;101(9):3275–3291. doi: 10.1002/jps.23164

Figure 2.

Figure 2

The efficacy of MTX-cIBR at different concentrations (0.05–5.0 mg/kg) in suppressing the increase in ankle diameters of arthritis rats compared to arthritis rats treated with vehicle, 0.05 mg/kg MTX, and normal rats. The results were from measuring two paws per rat with n = 7 for arthritis rats and n = 4 for normal rats. * = p-value < 0.05 when compared to vehicle-treated arthritis rats.